degenerative joint disease osteoarthritis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Received a Total Knee Joint prosthesis between September 2011 and May 2014; - Participated in the study assessing the mid-term wear of the N2Vac or X3 insert; - Sign informed consent of the proposed study.
Exclusion criteria
Exclusion criteria: - The patient was withdrawn from the previous study; - Revision/Removal of study device; - Patient withdrawal on patients own request; - Lost to Follow-Up; - Death of the patient; - The patient is unable or unwilling to sign the Informed Consent specific to this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoint is the in-vivo wear in mm of the N2Vac insert compared to the wear of the X3 insert, 10 years after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are migration and long-term survival of the Triathlon CS Peri-Apatite coated tibial component, clinical scores and radiographic aspects.Clinical scores are expressed by the scores of the following questionnaires: the Knee Society Score (KSS), EQ-5D-3L, SF-36 and Lower-Extremities Activity Scale (LEAS). | — |
Countries
Netherlands